TolleE.The Power of Now. Vancouver, British Columbia, Canada: Namaste; 2004.
2.
Biondi-ZoccaiGGAgostoniPSangiorgiG. Mastering the antegrade femoral artery access in patients with symptomatic lower limb ischemia: learning curve, complications, and technical tips and tricks. Catheter Cardiovasc Interv. 2006;68:835–842.
3.
FusaroMTashaniAMollichelliN. Retrograde pedal artery access for below-the-knee percutaneous revascularisation. J Cardiovasc Med (Hagerstown). 2007;8:216–218.
4.
FusaroMDallaPaola LBiondi-ZoccaiG.Pedal-plantar loop technique for a challenging below-the-knee chronic total occlusion: a novel approach to percutaneous revascularization in critical lower limb ischemia. J Invasive Cardiol. 2007;19:E34–E37.
5.
Biondi-ZoccaiGGSangiorgiGLotrionteM. Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251–260.
6.
AdamDJBeardJDClevelandT; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934.
7.
Biondi-ZoccaiGSangiorgiGD’AscenzoF. Drug-eluting balloons for peripheral artery disease: a meta-analysis of 7 randomized clinical trials and 643 patients. Int J Cardiol. 2013;168:570–571.
8.
GiordanoAFerraroPCorcioneN. Endovascular therapy for infrainguinal artery disease with coronary devices: a retrospective observational study comparing drug-eluting stents versus bioresorbable vascular scaffolds [published online March 15, 2016]. Angiology. doi:10.1177/0003319716637802.
9.
KatsanosKKitrouPSpiliopoulosS. Comparative effectiveness of plain balloon angioplasty, bare metal stents, drug-coated balloons, and drug-eluting stents for the treatment of infrapopliteal artery disease: Systematic review and Bayesian network meta-analysis of randomized controlled trials. J Endovasc Ther. 2016;23:851–863.
10.
Biondi-ZoccaiG, ed. Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison. Hauppauge, NY: Nova Science; 2014.
11.
Biondi-ZoccaiG, ed. Umbrella Reviews. Evidence Synthesis With Overviews of Reviews and Meta-Epidemiologic Studies. Cham, Switzerland: Springer International; 2016.
12.
XiaoYChenZYangY. Network meta-analysis of balloon angioplasty, nondrug metal stent, drug-eluting balloon, and drug-eluting stent for treatment of infrapopliteal artery occlusive disease [published online August 25, 2016]. Diagn Interv Radiol. doi:10.5152/dir.2016.15430.
13.
Biondi-ZoccaiGSangiorgiGModenaMG.Devices for infrainguinal endovascular therapy: menu à la carte or table d’hôte?J Endovasc Ther. 2011;18:638–641.
14.
GiacchiGOrtega-PazLBrugalettaS. Bioresorbable vascular scaffolds technology: current use and future developments. Med Devices (Auckl). 2016;9:185–198.
15.
GiordanoAMessinaSBiondi-ZoccaiG.Successful treatment of a subclavian artery stenosis with a coronary bioresorbable vascular scaffold. J Endovasc Ther. 2016;23:653–656.
16.
GiordanoAFerraroPCorcioneN. Successful treatment of recurrent carotid in-stent restenosis and drug-eluting balloon failure with a coronary bioresorbable vascular scaffold: A case report. Int J Surg Case Rep. 2016;21:78–82.
17.
CarnevaleRLoffredoLNocellaC. Epicatechin and catechin modulate endothelial activation induced by platelets of patients with peripheral artery disease. Oxid Med Cell Longev. 2014;2014:691015.